Success Metrics

Clinical Success Rate

100.0%

Based on 5 completed trials

Completion Rate

100%(5/5)

Active Trials

0(0%)

Results Posted

20%(1 trials)

Phase Distribution

Ph phase_2

29%

Ph phase_1

71%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution7 total trials

Phase 1Safety & dosage

5(71.4%)

Phase 2Efficacy & side effects

2(28.6%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(5)

Terminated(2)

Detailed Status

Completed5

Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 15 (71.4%)

Phase 22 (28.6%)

Trials by Status

withdrawn229%

completed571%

Recent Activity

0 active trials

Showing 5 of 7

completedphase_2

Clinical Trials (7)

Showing 7 of 7 trials

NCT04028388Phase 2

ModraDoc006/r vs Docetaxel IV in Metastatic Prostate Cancer

Completed

NCT05242926Phase 1

Absorption and Excretion of Oral Docetaxel

Withdrawn

NCT03136640Phase 1

ModraDoc006/r in Metastatic Castration-resistant Prostate Cancer

Completed

NCT05084456Phase 1

Oral Docetaxel in Patients With Normal or Impaired Liver Function

Withdrawn

NCT03150368Phase 1

Extended Use of ModraDoc006/r

Completed

NCT03147378Phase 1

Food Effect Study of ModraDoc006 in Combination With Ritonavir

Completed

NCT03890744Phase 2

ModraDoc006/r in Patients With Breast Cancer

Completed

All 7 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 7